CCL5 and ovarian cancer: Induces G0/G1 cell cycle arrest in ovarian cancer cells by suppressing cyclin E, and increases ROS levels, inhibiting Akt pathway. Suppresses pro-tumor factors (MMP-9, RANTES, VEGF) in TAMs, limiting tumor-supportive macrophage activity.